“According to a new report published by Introspective Market Research, Respiratory Devices Market by Product (Therapeutic Devices, Monitoring & Diagnostic Devices, Consumables & Accessories), and End-User (Hospitals, Home Care Settings, Ambulatory Care Centers), The Global Respiratory Devices Market Size Was Valued at USD 24.44 Billion in 2024 and is Projected to Reach USD 61.55 Billion by 2035, Growing at a CAGR of 8.76%.”

The Respiratory Devices Market encompasses a wide range of medical equipment designed for the diagnosis, monitoring, and treatment of respiratory illnesses, which have seen a massive rise in global prevalence. This includes devices like ventilators, oxygen concentrators, nebulizers, Positive Airway Pressure (PAP) devices, and spirometers. These innovative devices offer critical support and improved patient outcomes compared to traditional, less precise methods, often enabling non-invasive therapy and home-based care.

The products in this market are essential in managing chronic and acute respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), asthma, sleep apnea, and infectious diseases like pneumonia. Beyond hospitals and clinics, the market is profoundly shaped by the rising demand for sophisticated, user-friendly portable and home care devices. This shift provides patients with increased mobility, comfort, and the ability to self-manage their conditions, thereby reducing the burden on healthcare facilities and improving the overall quality of life for millions suffering from breathing difficulties.

Market Segmentation

The Respiratory Devices Market is segmented into Product, End-User, and Indication. By Product, the market is categorized into (Therapeutic Devices, Monitoring & Diagnostic Devices, Consumables & Accessories). By End-User, the market is categorized into (Hospitals, Home Care Settings, Ambulatory Care Centers). By Indication, the market is categorized into (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Infectious Diseases).

Growth Driver

The primary growth driver for the Respiratory Devices Market is the significantly rising global prevalence of Chronic Respiratory Diseases (CRDs), including COPD and asthma, coupled with the accelerating aging of the global population. CRDs are among the leading causes of death and disability worldwide, exacerbated by factors such as increasing air pollution, high rates of tobacco smoking, and environmental degradation. As the geriatric demographic expands, susceptibility to these conditions naturally increases, driving a continuous and urgent demand for effective, reliable respiratory support, diagnostic tools, and therapeutic devices. This demographic and environmental convergence ensures a robust trajectory for market expansion, pushing manufacturers toward more advanced and accessible solutions.

Market Opportunity

A key market opportunity lies in the rapid shift towards home healthcare settings and the proliferation of portable, connected respiratory devices. Technological advancements, such as the development of compact, lightweight oxygen concentrators, smart inhalers, and AI-powered remote patient monitoring (RPM) systems, are transforming patient care. This transition enables patients with chronic conditions to receive high-quality care, monitor their health parameters in real-time, and adhere to treatment plans more effectively from the comfort of their homes. For market players, this trend opens lucrative avenues for product innovation, strategic partnerships with telehealth providers, and expansion into emerging markets where demand for accessible, decentralized care solutions is skyrocketing.

 Detailed Segmentation

Line below: The Respiratory Devices Market is segmented on the basis of Product, End-User, and Indication.

Product

The Product segment is further classified into Therapeutic Devices, Monitoring & Diagnostic Devices, and Consumables & Accessories. Among these, the Therapeutic Devices sub-segment is estimated to account for the highest market share in 2024. Therapeutic devices, which include ventilators, nebulizers, oxygen concentrators, and PAP devices, are indispensable for providing critical, life-sustaining support and ongoing management for patients with severe acute and chronic respiratory failure. The high initial cost, frequent upgrades due to technological advancements, and the constant demand for these devices in managing conditions like COPD and sleep apneawhich require lifelong interventionsolidify their dominance in the market. Furthermore, the push towards non-invasive ventilation techniques continues to drive innovation and adoption in this category.

End-User

The End-User segment is further classified into Hospitals, Home Care Settings, and Ambulatory Care Centers. Among these, the Hospitals sub-segment accounted for the highest market share in 2024. Hospitals remain the primary end-users due to their central role in critical and acute care, where advanced, high-cost respiratory equipment like high-end ventilators and anesthesia machines are mandatory. The increasing number of patient admissions globally for severe respiratory distress, coupled with continuous governmental and private investment in expanding hospital capacity and intensive care units (ICUs), ensures this segment’s leadership. Hospitals serve as the main point of care for initial diagnosis, emergency treatment, and complex procedures, requiring a substantial and constant inventory of a full spectrum of respiratory devices.

 Some of The Leading/Active Market Players Are-

·         Koninklijke Philips N.V. (Netherlands)

·         Medtronic plc (Ireland)

·         ResMed Inc. (U.S.)

·         Fisher & Paykel Healthcare Corporation Limited (New Zealand)

·         Drägerwerk AG & Co. KGaA (Germany)

·         GE HealthCare (U.S.)

·         Masimo Corporation (U.S.)

·         Teleflex Incorporated (U.S.)

·         Getinge AB (Sweden)

·         Becton, Dickinson, and Co. (BD) (U.S.)

·         CAIRE Inc. (U.S.)

·         Vyaire Medical, Inc. (U.S.)

·         Inogen Inc. (U.S.)

·         Nihon Kohden Corporation (Japan)

·         OMRON Corporation (Japan) and other active players.

Key Industry Developments

 In February 2024, Aptar Pharma launched HeroTracker Sense, a new digital respiratory health solution that transforms traditional pressurized metered dose inhalers (pMDIs) into smart, connected devices.

This innovation addresses the critical issue of patient adherence and poor inhalation technique, which often leads to ineffective treatment. HeroTracker Sense is designed to track usage, provide personalized reminders, and ensure patients use their inhalers correctly, transmitting real-time data to healthcare providers via connected apps. This development is a significant step in the digital transformation of respiratory care, making therapy management more data-driven and personal.

In November 2021, Cipla, Inc. launched Spirofy, a pneumotach-based portable, wireless spirometer, designed for use by patients at home for the diagnosis and monitoring of respiratory disorders.

Spirofy represents a major push toward decentralized and convenient respiratory diagnostics. Its portable and wireless design allows for spirometry testing to be performed outside of traditional clinical settings, greatly increasing accessibility for patients in remote areas and those with limited mobility. This helps facilitate earlier diagnosis of conditions like COPD and asthma, enabling timely intervention and management.

 Key Findings of the Study

·         The Therapeutic Devices segment (including ventilators and oxygen concentrators) dominates the market share due to critical life-support needs.

·         The Hospitals end-user segment retains the largest share, driven by their role in acute and emergency care for respiratory illnesses.

·         Rising prevalence of chronic respiratory diseases (COPD, asthma) and the aging population are the major growth drivers.

·         A significant market trend is the surging demand for portable, smart, and connected devices for use in home care settings.

·         North America is the leading regional market, supported by advanced healthcare infrastructure and high disease awareness.

About Us

At Introspective Market Research Private Limited, we are a forward-thinking research consulting firm committed to driving growth in the Respiratory Devices Market. With deep insights, strategic solutions, and holistic research, we empower businesses to achieve success and dominance in the global Respiratory Devices Market industry.

More Info:- https://introspectivemarketresearch.com/reports/respiratory-devices-market/

📞 Contact Us Introspective Market Research Pvt. Ltd.

 Phone: +91-91753-37569

 Email: sales@introspectivemarketresearch.com

 Web: www.introspectivemarketresearch.com